Inhibitors of protein aggregation: WO2007110629

Claude Michel Wischik; Janet Elizabeth Rickard; David Horsley; Charles Robert Harrington

Inhibitors of protein aggregation: WO2007110629

Claude Michel Wischik (Inventor), Janet Elizabeth Rickard (Inventor), David Horsley (Inventor), Charles Robert Harrington (Inventor)

Applied Health Sciences

Research output: Patent

9 Downloads (Pure)

Abstract

This patent deonstrates a series of compounds that inhibit the aggregation of synuclein as a means for disease modification in Parkinson's disease. Granted in US, AU and SG.

Original language	English
Patent number	WO2007110629
Publication status	Published - 4 Oct 2007

Access to Document

WO2007110629

Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease
Claude Wischik (Participant), Charles Harrington (Participant), John Storey (Participant), Janet Rickard (Participant), David Horsley (Participant), Thomas Baddeley (Participant), Steven Kemp (Participant), James Sinclair (Participant), Claudia Zabke (Participant), F. Theuring (Participant), F Stamer (Participant) & C Marshall (Participant)
Impact: Health and Wellbeing, Economic and/or Commercial

Cite this

@misc{629119ee436e442e8e4adacda25de462,

title = "Inhibitors of protein aggregation: WO2007110629",

abstract = "This patent deonstrates a series of compounds that inhibit the aggregation of synuclein as a means for disease modification in Parkinson's disease. Granted in US, AU and SG.",

author = "Wischik, {Claude Michel} and Rickard, {Janet Elizabeth} and David Horsley and Harrington, {Charles Robert}",

year = "2007",

month = oct,

day = "4",

language = "English",

type = "Patent",

note = "WO2007110629",

}

TY - PAT

T1 - Inhibitors of protein aggregation

T2 - WO2007110629

AU - Wischik, Claude Michel

AU - Rickard, Janet Elizabeth

AU - Horsley, David

AU - Harrington, Charles Robert

PY - 2007/10/4

Y1 - 2007/10/4

N2 - This patent deonstrates a series of compounds that inhibit the aggregation of synuclein as a means for disease modification in Parkinson's disease. Granted in US, AU and SG.

AB - This patent deonstrates a series of compounds that inhibit the aggregation of synuclein as a means for disease modification in Parkinson's disease. Granted in US, AU and SG.

M3 - Patent

M1 - WO2007110629

ER -

Inhibitors of protein aggregation: WO2007110629

Abstract

Access to Document

Fingerprint

Impacts

Discovery and commercialisation of an entirely new drug for the treatment of Alzheimer's disease

Cite this